Innoviva, Inc. (INVA)
20.94
+0.23
(+1.11%)
USD |
NASDAQ |
Dec 10, 11:14
Innoviva Profit Margin (Quarterly): 80.81% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 33.55% |
| Eli Lilly & Co. | 31.72% |
| Merck & Co., Inc. | 33.68% |
| Pfizer Inc. | 21.32% |
| Bristol Myers Squibb Co. | 17.96% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.06% |
| Return on Assets | 9.67% |
| Return on Invested Capital | 10.86% |
| Gross Profit Margin (Quarterly) | 67.87% |
| Operating Margin (Quarterly) | 31.08% |
| Return on Net Operating Assets | 34.83% |